Angiotensin II Inhibits Neuronal Nitric Oxide Synthase Activation Through the ERK1/2-RSK Signaling Pathway to Modulate Central Control of Blood PressureWenhan Cheng, Ching‐Jiunn Tseng, Pei‐Jung Lu et al.|Circulation Research|2010Cited by 73
<scp>GPCR</scp> dimerization in brainstem nuclei contributes to the development of hypertensionGwo‐Ching Sun, Ching‐Jiunn Tseng, Mei‐Chi Hsu et al.|British Journal of Pharmacology|2015Cited by 27
Central nicotinic acetylcholine receptor involved in Ca<sup>2+</sup>‐calmodulin‐endothelial nitric oxide synthase pathway modulated hypotensive effectsPei‐Wen Cheng, Ching‐Jiunn Tseng, Pei‐Jung Lu et al.|British Journal of Pharmacology|2010Cited by 25
Simvastatin induces a central hypotensive effect via Ras‐mediated signalling to cause <scp>eNOS</scp> up‐regulationWen‐Han Cheng, Ching‐Jiunn Tseng, Wen‐Yu Ho et al.|British Journal of Pharmacology|2013Cited by 23
Central hypotensive effects of neuropeptide Y are modulated by endothelial nitric oxide synthase after activation by ribosomal protein S6 kinasePei‐Wen Cheng, Ching‐Jiunn Tseng, Alexander T.H. Wu et al.|British Journal of Pharmacology|2012Cited by 17